Cargando…
Carisoprodol Abuse in Adolescence
Carisoprodol (i.e. Soma, Soprodol, Vanadom) is a muscle relaxant prescribed to relieve symptoms of muscle pain. Carisoprodol's addiction potential in adults has been well-established through case reports in the past. Carisoprodol abuse in adolescents has been reported in the ‘Monitoring the Fut...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746313/ https://www.ncbi.nlm.nih.gov/pubmed/33354469 http://dx.doi.org/10.7759/cureus.11525 |
_version_ | 1783624771355803648 |
---|---|
author | Gupta, Mayank |
author_facet | Gupta, Mayank |
author_sort | Gupta, Mayank |
collection | PubMed |
description | Carisoprodol (i.e. Soma, Soprodol, Vanadom) is a muscle relaxant prescribed to relieve symptoms of muscle pain. Carisoprodol's addiction potential in adults has been well-established through case reports in the past. Carisoprodol abuse in adolescents has been reported in the ‘Monitoring the Future’ study since 2007, but no case studies or research has been published to date. Due to its relatively short half-life, tolerance and dependence develop quite quickly, leading to negative mental health outcomes. Awareness and education among health care providers remain critical to screen and treat this condition. |
format | Online Article Text |
id | pubmed-7746313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-77463132020-12-21 Carisoprodol Abuse in Adolescence Gupta, Mayank Cureus Psychiatry Carisoprodol (i.e. Soma, Soprodol, Vanadom) is a muscle relaxant prescribed to relieve symptoms of muscle pain. Carisoprodol's addiction potential in adults has been well-established through case reports in the past. Carisoprodol abuse in adolescents has been reported in the ‘Monitoring the Future’ study since 2007, but no case studies or research has been published to date. Due to its relatively short half-life, tolerance and dependence develop quite quickly, leading to negative mental health outcomes. Awareness and education among health care providers remain critical to screen and treat this condition. Cureus 2020-11-17 /pmc/articles/PMC7746313/ /pubmed/33354469 http://dx.doi.org/10.7759/cureus.11525 Text en Copyright © 2020, Gupta et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Psychiatry Gupta, Mayank Carisoprodol Abuse in Adolescence |
title | Carisoprodol Abuse in Adolescence |
title_full | Carisoprodol Abuse in Adolescence |
title_fullStr | Carisoprodol Abuse in Adolescence |
title_full_unstemmed | Carisoprodol Abuse in Adolescence |
title_short | Carisoprodol Abuse in Adolescence |
title_sort | carisoprodol abuse in adolescence |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746313/ https://www.ncbi.nlm.nih.gov/pubmed/33354469 http://dx.doi.org/10.7759/cureus.11525 |
work_keys_str_mv | AT guptamayank carisoprodolabuseinadolescence |